间充质干细胞外泌体治疗肺部疾病的研究进展

doi:10.16352/j.issn.1001-6325.2023.01.0192

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (1): 192-195.doi: 10.16352/j.issn.1001-6325.2023.01.0192

间充质干细胞外泌体治疗肺部疾病的研究进展

陈莉莉¹, 孙永红^2*, 雷晓燕², 王建军², 陈星星², 鲍柏辛¹

1.甘肃中医药大学第一临床医学院,甘肃兰州 730000;
2.甘肃省人民医院儿科,甘肃兰州 730000

收稿日期:2022-04-02 修回日期:2022-09-29 发布日期:2022-12-27
通讯作者: ^*sunyonghong7615@126.com
基金资助:
甘肃省国际科技合作专项(18YF1WA040);甘肃省自然科学基金(20JR10RA385);甘肃省人民医院院内科研基金(19SYPYB-24,18GSSY3-4)

Research advances in the treatment of lung diseases based on mesenchymal stem cell exosomes

CHEN Lili¹,SUN Yonghong^2*,LEI Xiaoyan²,WANG Jianjun²,CHEN Xingxing²,BAO Baixin¹

1. First College of Clinical Medicine,Gansu University Traditional Chinese Medicine,Lanzhou 730000;
2. Department of Pediatrics, Gansu Provincial Peoples Hospital,Lanzhou 730000,China

Received:2022-04-02 Revised:2022-09-29 Published:2022-12-27
Contact: ^*sunyonghong7615@126.com

摘要/Abstract

摘要： 间充质干细胞来源的外泌体(MSC-EXOs)携带着脂质、蛋白、核酸等信号物质,在细胞间通讯、免疫调节、血管再生中发挥着重大作用。MSC-EXOs在肺动脉高压、肺纤维化等肺部疾病中通过调控不同的信号通路、减少细胞炎性反应、调节免疫细胞功能、改善线粒体功能、促进血管生成、减轻肺血管重构等途径改善肺组织的功能,治疗肺部疾病,从而为今后难治性肺部疾病的治疗提供新思路。

关键词: 间充质干细胞, 外泌体, 肺部疾病

Abstract: Exosomes secreted by mesenchymal stem cell(MSC-EXOs)carry lipids,proteins,nucleic acids and other signaling substances, which play an important role in intercellular communication, immune regulation and vascular regeneration. MSC-EXOs in pulmonary hypertension, pulmonary fibrosis and other lung diseases can improve the function of the lung tissue and treat lung diseases by regulating different signaling pathways, reducing cell inflammatory reaction, regulating immune function, improving the function of mitochondria, promoting angiogenesis, reducing pulmonary vascular remodeling and etc.,which provides new ideas for the treatment of refractory lung diseases in the future.

Key words: mesenchymal stem cell, exosome, lung disease

中图分类号:

R563

陈莉莉, 孙永红, 雷晓燕, 王建军, 陈星星, 鲍柏辛. 间充质干细胞外泌体治疗肺部疾病的研究进展[J]. 基础医学与临床, 2023, 43(1): 192-195.

CHEN Lili,SUN Yonghong,LEI Xiaoyan,WANG Jianjun,CHEN Xingxing,BAO Baixin. Research advances in the treatment of lung diseases based on mesenchymal stem cell exosomes[J]. Basic & Clinical Medicine, 2023, 43(1): 192-195.

参考文献

[1] Dutra SJ,Su Y,Calfee CS,et al.Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS[J].Eur Respir J,2021,58:10.1183/13993003.02978-2020.
[2] Xu J,Xu D,Yu Z,et al.Exosomal miR-150 partially attenuated acute lung injury by mediating microvascular endothelial cells and MAPK pathway[J].Biosci Rep,2022,42.doi:10.1042/BSR20203363.
[3] Cheng H,Ding J,Tang G, et al.Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway[J].Mol Med,2021,27:128.doi:10.1186/s10020-021-00393-1.
[4] Lou G,Chen L,Xia C,et al.miR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway[J].J Exp Clin Cancer Res,2020,39:4.doi:10.1186/s13046-019-1512-5.
[5] Zhang Z,Ge L,Zhang S,et al.The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway[J].J Cell Mol Med,2020,24:13938-13948.
[6] Klinger JR,Pereira M,Del TM,et al.Mesenchymal stem cell extracellular vesicles reverse sugen/hypoxia pulmon-ary hypertension in rats[J].Am J Respir Cell Mol Biol,2020,62:577-587.
[7] Hemnes AR,Luther JM,Rhodes CJ et al.Human PAH is characterized by a pattern of lipid-related insulin resistance[J].JCI Insight,2019,4.doi:10.1172/jci.insight.123611.
[8] Hemnes AR,Fessel JP, X,et al.BMPR2 dysfunction impairs insulin signaling and glucose homeostasis in cardiomyocytes[J].Am J Physiol Lung Cell Mol Physiol,2020,318:L429-L441.
[9] Hogan SE,Rodriguez SM,Cheadle J,et al.Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension[J].Am J Physiol Lung Cell Mol Physiol,2019,316:L723-L737.
[10] Mansouri N,Willis GR,Fernandez-Gonzalez A,et al.Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes[J].JCI Insight,2019,4.doi:10.1172/jci.insight.128060.
[11] Yang J,Hu H,Zhang S,et al.Human umbilical cord mesenchymal stem cell-derived exosomes alleviate pulmonary fibrosis in mice by inhibiting epithelial-mesenchymal transition[J].Nan Fang Yi Ke Da Xue Xue Bao,2020,40:988-994.
[12] Sun L,Zhu M,Feng W,et al.Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage[J].Oxid Med Cell Longev,2019,2019:4506303.doi:10.1155/2019/4506303.
[13] Tan JL,Lau SN,Leaw B,et al.Amnion epithelial cell-derived exosomes restrict lung injury and enhance endogenous lung repair[J].Stem Cells Transl Med,2018,7:180-196.
[14] Sengupta V,Sengupta S,Lazo A, et al.Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19[J].Stem Cells Dev,2020,29:747-754.
[15] Zhu YG,Shi MM,Monsel A,et al.Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study[J].Stem Cell Res Ther,2022,13:220.doi:10.1186/s13287-022-02900-5.
[16] Kaspi H,Semo J,Abramov N,et al.MSC-NTF(NurOwn) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model[J].Stem Cell Research & Therapy,2021,12:72.doi:10.1186/s13287-021-02143-w.
[17] Willis GR, Fernandez-Gonzalez A, Anastas J,et al.Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation[J].Am J Respir Crit Care Med,2018,197:104-116.
[18] Braun RK,Chetty C,Balasubramaniam V,et al.Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia[J].Biochem Biophys Res Commun,2018,503:2653-2658.
[19] Dong B,Wang C,Zhang J,et al.Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization[J].Stem Cell Res Ther,2021,12:204.doi:10.1186/s13287-021-02244-6.
[20] Song J,Zhu XM,Wei QY.MSCs reduce airway remodeling in the lungs of asthmatic rats through the Wnt/beta-catenin signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24:11199-11211.
[21] Zhuansun Y,Du Y,Huang F,et al.MSCs exosomal miR-1470 promotes the differentiation of CD4(+)CD25(+)FOXP3(+) Tregs in asthmatic patients by inducing the expression of P27KIP1[J].Int Immunopharmacol,2019,77:105981.doi:10.1016/j.intimp.2019.105981.

间充质干细胞外泌体治疗肺部疾病的研究进展

Research advances in the treatment of lung diseases based on mesenchymal stem cell exosomes

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨蕴钊, 石美涵, 周诚, 白雪源. 间充质干细胞在肾脏疾病治疗中的应用进展[J]. 基础医学与临床, 2023, 43(1): 30-37.
[2]	周嘉航, 陈鋆瑶, 曹红翠. 间充质干细胞移植治疗肝脏疾病的研究进展[J]. 基础医学与临床, 2023, 43(1): 12-20.
[3]	姜俣, 钱海燕. 间充质干细胞治疗心肌梗死的研究进展[J]. 基础医学与临床, 2023, 43(1): 21-29.
[4]	商利鹏, 刘国祥, 丁晓燕, 李冰, 赵春华, 李霄霞. 间充质干细胞在衰老相关疾病应用中的研究进展[J]. 基础医学与临床, 2023, 43(1): 38-45.
[5]	汪海燕, 韩钦, 赵春华. 间充质干细胞的免疫调节可塑性及其临床应用策略[J]. 基础医学与临床, 2023, 43(1): 2-11.
[6]	张晓彤, 赵月纯, 朱镕嘉, 赵春华, 宋坪. 以“肾-三焦”系统诠释间充质干细胞实质[J]. 基础医学与临床, 2023, 43(1): 46-50.
[7]	阮锋, 李贺伟, 龚艳琳, 刘佳丽, 刘平. 过表达miR-217调控EZH2促进骨质疏松模型小鼠BM-MSCs成骨分化[J]. 基础医学与临床, 2022, 42(9): 1406-1413.
[8]	孙爱华, 赵艳秋, 王继灵. 老年慢性阻塞性肺部疾病急性加重期患者住院死亡的危险因素及预后[J]. 基础医学与临床, 2022, 42(9): 1414-1418.
[9]	吴文哲, 孙建伟, 付长秀, 黄李晨露, 郑永钦, 贺军栋. 脐带间充质干细胞修复皮肤创伤的研究进展[J]. 基础医学与临床, 2022, 42(11): 1771-1775.
[10]	董扬, 张芬, 李幸幸, 吴杰, 徐忠诚. 敲低miR-34c-5p抑制低氧诱导的大鼠骨髓间充质干细胞的凋亡[J]. 基础医学与临床, 2022, 42(11): 1690-1696.
[11]	李英杰, 杨庭楷, 纪志刚, 文进. 外泌体在前列腺癌诊疗中的研究进展[J]. 基础医学与临床, 2022, 42(1): 163-167.
[12]	李晓静, 王丽, 赵春华, 柳仁民, 马胜军, 李光耀, 任少达. 从药学视角探讨间充质干细胞产品研发的策略与进展[J]. 基础医学与临床, 2021, 41(9): 1338-1341.
[13]	刘晓玉, 施萍, 潘伯臣, 庞希宁. 人羊膜间充质干细胞无血清培养方法的建立[J]. 基础医学与临床, 2021, 41(8): 1181-1185.
[14]	陈民佳, 汪晓月, 陈客宏, 陆红祥. 间充质干细胞治疗肺纤维化的研究进展[J]. 基础医学与临床, 2021, 41(7): 1056-1059.
[15]	杨旭东, 于红亮, 李静, 赵春华. 巨噬细胞J774A.1外泌体促进结直肠癌细胞系MC38和CT26的增殖和迁移[J]. 基础医学与临床, 2021, 41(6): 799-804.